Response to: ‘We could be heroes: ethical issues with the pre-recruitment of research participants’ by D. Hunter
I am happy that my paper provoked a response from the Health Research Authority (HRA) and that they have taken the opportunity to clarify this area—I want to respond in part to some of their comments, while accepting that some are accurate.1 ,2While I am gladdened that generic advertising must now b...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
Published: |
2016
|
In: |
Journal of medical ethics
Year: 2016, Volume: 42, Issue: 3, Pages: 206 |
Online Access: |
Volltext (JSTOR) Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
Summary: | I am happy that my paper provoked a response from the Health Research Authority (HRA) and that they have taken the opportunity to clarify this area—I want to respond in part to some of their comments, while accepting that some are accurate.1 ,2While I am gladdened that generic advertising must now be submitted for review for stage 1 clinical trials since 2013 (there was some crossover between the original conception of the paper and this time period), I have to say this is at best only partially reassuring.First, … |
---|---|
ISSN: | 1473-4257 |
Contains: | Enthalten in: Journal of medical ethics
|
Persistent identifiers: | DOI: 10.1136/medethics-2015-103262 |